Skip to main content

Advertisement

Figure 2 | BMC Cancer

Figure 2

From: Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization

Figure 2

PharmGKB doxorubicin pharmacodynamic and pharmacokinetic pathways. Doxorubicin metabolic pathways were retrieved from the PharmGKB website (http://www.pharmgkb.org/drug/PA449412#tabview=tab4&subtab=33), combined, and used for further analysis. All diagrams are copyright PharmGKB. Used with permission from PharmGKB and Stanford University. (A) pharmacodynamics (B) Pharmacokinetics.

Back to article page